Off Patent
December 2026

Signifor

pasireotide diaspartate

Recordati Rare Diseases Inc

Solution (subcutaneous) · NDA 200677

Last listed protection ends
December 14, 2026

The FDA lists 1 patent for Signifor, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 7,473,761
    Claims the drug substance and the drug product